Login
Navigate Fool.com
Will DXCM beat
the market?

DexCom, Inc.

NASDAQ: DXCM

Community Rating: 1 Star: Ominous

36.58 0.55 (1.53%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $36.03
Previous Close $36.03
Daily Range $35.35 - $36.99
52-Week Range $15.04 - $49.83
Market Cap $2.7B
P/E Ratio -87.10
Dividend (Yield) $0.00 (0.0%)
Volume 693,073
Average Daily Volume 1,039,431
Current FY EPS -$0.09

How do you think DXCM
will perform against the market?

Top DXCM Bull/Bear Pitches

 

OneStarHero (0.33)
Submitted June 5, 2007

I use their products to monitor my glucose levels, and I DONT EVEN HAVE DIABETES. That is how awesome they are.

5 Replies Reply Report this Post
 

BiLoandWise (< 20)
Submitted May 4, 2008

Their devices haven't been selling, their financials are awful, the stock price has been plummeting and they're headed toward bankruptcy.

0 Replies Reply Report this Post

News & Commentary

1 Stock Helping Revolutionize Diabetes Monitoring

New products in development with partners Johnson & Johnson and Tandem could help Dexcom outmaneuver its chief competitor, Medtronic.

First Week of DXCM May 17th Options Trading

DexCom Larger Than S&P 500 Component Cliffs Natural Resources

Mid-Morning Market Update: Markets Open Higher; Groupon Issues Weak Outlook

What to Watch at DexCom, Smith & Nephew, and Endo Health Solutions This Morning

DexCom, Smith & Nephew, and Endo Health Solutions could be big health care stories this morning. Read on to find out why.

Google Could Disrupt These 3 Medical Industries Within 10 Years

Can tech giant Google disrupt these three medical industries, currently dominated by Roche, DexCom, and Allscripts?

3 Ways Johnson & Johnson Is Revolutionizing Diabetes Care

Johnson & Johnson rarely gets much attention for its efforts in diabetes treatments. Let’s take a look at three of the company’s interesting new efforts to treat diabetes, and how they could affect companies like AstraZeneca, Bristol-Myers Squibb, Medtronic, DexCom, and Sanofi.

Dexcom Inc.: The Best Medical Device Companies of 2013

New technology that tracks blood sugar is driving sales and share higher at Dexcom.

A Trio of Stock Prospects in Medical Devices

What is the outlook for AngioDynamics, DexCom, and Abiomed?

Why DexCom Shares Soared

Is this meaningful? Or just another movement?

See More DXCM News...

Sector

Healthcare

Industry

Healthcare Information Services

DexCom, Inc. (DXCM) Description

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes. Website: http://www.dexcom.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks